Stago

Stago, established in 1945, is a distinguished global entity in the in vitro diagnostics (IVD) sector, recognized as a worldwide reference for haemostasis and thrombosis testing. The company exercises comprehensive end-to-end control across its entire business spectrum, including research and development, manufacturing, logistics, marketing, sales, and international distribution. Its principal reagent manufacturing facility operates under stringent ISO 13485, ISO 9001, and ISO 14001 certifications, underscoring a commitment to quality and environmental management. Stago's core industrial operations are centered in France, where the majority of its nearly 2,600 employees are situated, contributing to its robust manufacturing capabilities in the Test & Measurement Equipment and Manufacturing industries, aligning with #technology and #b2b hashtags.

The company's strategic geographic expansion includes dedicated R&D and production centers in the United States, Netherlands, Germany, Ireland, and China, complementing its French base. Since its American subsidiary's inception in 1985, Stago has significantly broadened its distribution network, establishing 17 new affiliates in key international markets. With a revenue of $76.5M and an employee range of 1,000-5,000 employees, Stago markets over 350 products, comprising advanced haemostasis test instruments and reagents. Its headquarters are located in Forest Hill, Victoria, Australia, serving as a hub for its extensive global operations.

Stago is dedicated to supporting biomedical laboratories worldwide with reliable, comprehensive solutions for coagulation and thrombosis diagnostics. This commitment is reinforced by a licensed training center providing specialized theoretical and practical courses for haemostasis and thrombosis professionals. Continuous investment in research and innovation, fueled by a diverse, multidisciplinary workforce, positions Stago as aView more...